SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,051,534 | +184.3% | 391,231 | +357.2% | 0.05% | +152.6% |
| Q1 2022 | $2,832,000 | -69.6% | 85,572 | -60.9% | 0.02% | -69.4% |
| Q4 2021 | $9,318,000 | +322.0% | 219,051 | +339.5% | 0.06% | +313.3% |
| Q3 2021 | $2,208,000 | +135.6% | 49,841 | +298.1% | 0.02% | +114.3% |
| Q1 2021 | $937,000 | -95.4% | 12,520 | -94.7% | 0.01% | -96.1% |
| Q4 2020 | $20,325,000 | +28.5% | 234,939 | -9.2% | 0.18% | +8.5% |
| Q3 2020 | $15,819,000 | +48.5% | 258,819 | +1.0% | 0.16% | +42.6% |
| Q2 2020 | $10,656,000 | +697.6% | 256,275 | +450.9% | 0.12% | +576.5% |
| Q1 2020 | $1,336,000 | +239.1% | 46,516 | +752.9% | 0.02% | +325.0% |
| Q4 2019 | $394,000 | +13.9% | 5,454 | +153.7% | 0.00% | -33.3% |
| Q1 2018 | $346,000 | -68.1% | 2,150 | -90.9% | 0.01% | -68.4% |
| Q3 2016 | $1,085,000 | -38.6% | 23,560 | -59.8% | 0.02% | -48.6% |
| Q2 2016 | $1,768,000 | -9.2% | 58,670 | -3.4% | 0.04% | -9.8% |
| Q1 2016 | $1,947,000 | – | 60,720 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |